Identification and characterization of cytochrome P4502D6*56B (CYP2D6*56B), a novel allele associated with the poor metabolizer phenotype.

被引：0
|
作者：
Gaedigk, A. [1 ]
Eklund, J. D. [1 ]
Pearce, R. E. [1 ]
Leeder, J. S. [1 ]
Alander, S. W. [1 ]
Bradford, L. D. [1 ]
Kennedy, M. J. [1 ]
机构：
[1] Univ Louisville, Childrens Mercy Hosp, Morehouse Sch Med, Kansas City, MO USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2007年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [1] Identification and characterization of CYP2D6*56B, an allele associated with the poor metabolizer phenotype
    Gaedigk, A.
    Eklund, J. D.
    Pearce, R. E.
    Leeder, J. S.
    Alander, S. W.
    Phillips, M. S.
    Bradford, L. D.
    Kennedy, M. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (06) : 817 - 820
  • [2] Cytochrome P4502D6 (CYP2D6) bioelectrode for fluoxetine
    Iwuoha, EI
    Wilson, A
    Howel, M
    Mathebe, NGR
    Montane-Jaime, K
    Narinesingh, D
    Guiseppi-Elie, A
    ANALYTICAL LETTERS, 2004, 37 (05) : 929 - 941
  • [3] Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans
    A Gaedigk
    A Bhathena
    L Ndjountché
    R E Pearce
    S M Abdel-Rahman
    S W Alander
    L DiAnne Bradford
    J Steven Leeder
    The Pharmacogenomics Journal, 2005, 5 : 173 - 182
  • [4] Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans
    Gaedigk, A
    Bhathena, A
    Ndjountché, L
    Pearce, RE
    Abdel-Rahman, SM
    Alander, SW
    Bradford, LD
    Leeder, JS
    PHARMACOGENOMICS JOURNAL, 2005, 5 (03): : 173 - 182
  • [5] Erratum: Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans
    A Gaedigk
    A Bhathena
    L Ndjountché
    R E Pearce
    S M Abdel-Rahman
    S W Alander
    L DiAnne Bradford
    J Steven Leeder
    The Pharmacogenomics Journal, 2005, 5 : 276 - 276
  • [6] Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data
    Gaedigk, A
    Gotschall, RR
    Forbes, NS
    Simon, SD
    Kearns, GL
    Leeder, JS
    PHARMACOGENETICS, 1999, 9 (06): : 669 - 682
  • [7] A NOVEL CYP2D6 ALLELE WITH AN ABOLISHED SPLICE RECOGNITION SITE ASSOCIATED WITH THE POOR METABOLIZER PHENOTYPE
    MAREZ, D
    SABBAGH, N
    LEGRAND, M
    LOGUIDICE, JM
    BOONE, P
    BROLY, F
    PHARMACOGENETICS, 1995, 5 (05): : 305 - 311
  • [8] Accuracy of cytochrome P4502D6 (CYP2D6): Phenotype assignment from genotyping data.
    Gaedigk, A
    Gotschall, RR
    Forbes, NS
    Simon, SD
    Leeder, JS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 139 - 139
  • [9] Inhibition of cytochrome P4502D6 (CYP2D6) by terbinafine (TER) in vitro.
    Abdel-Rahman, SM
    Marcucci, K
    Boge, T
    Gotschall, RR
    Kearns, GL
    Leeder, JS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 135 - 135
  • [10] Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity:: Characterization of gene duplication events
    Gaedigk, A.
    Ndjountche, L.
    Divakaran, K.
    Bradford, L. DiAnne
    Zineh, I.
    Oberlander, T. F.
    Brousseau, D. C.
    McCarver, D. G.
    Johnson, J. A.
    Alander, S. W.
    Riggs, K. Wayne
    Leeder, J. Steven
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (02) : 242 - 251
12345